Aspergillus niger gg Շվեյցարիա - ֆրանսերեն - Swissmedic (Swiss Agency for Therapeutic Products)

aspergillus niger gg

boiron sa - aspergillus niger - d10, d, c5 d; lm/q1, d; k30, d - homöopathisch

Aspergillus compositum Շվեյցարիա - ֆրանսերեն - Swissmedic (Swiss Agency for Therapeutic Products)

aspergillus compositum

ebi-pharm ag - candida parapsilosis, d12, 0.33 ml / 1ml; penicillium festgestellt, d12, 0.33 ml / 1ml; aspergillus einzigartigen schwarz, d12, 0.33 ml / 1ml - tropfen / spray - d - candida parapsilosis, d12, 0,33 ml / 1 ml; penicillium noté, d12, 0,33 ml / 1 ml; aspergillus noir unique, d12, 0,33 ml / 1 ml - homöopathisch

Provokations-Test Aspergillus fumigatus Pulver und Lösungsmittel zur Herstellung einer Provokationslösung Շվեյցարիա - ֆրանսերեն - Swissmedic (Swiss Agency for Therapeutic Products)

provokations-test aspergillus fumigatus pulver und lösungsmittel zur herstellung einer provokationslösung

allergopharma ag - fungi allergeni extractum (aspergillus fumigatus) - pulver und lösungsmittel zur herstellung einer provokationslösung - praeparatio cryodesiccata: fungi allergeni extractum (aspergillus fumigatus) 25000 u., mannitolum, pro vitro. solvens: natrii chloridum, natrii hydrogenocarbonas, phenolum, aqua q.s. ad solutionem pro 1 ml. - diagnostic de l'allergie - allergène: diagnostic

Prick-Test Aspergillus fumigatus Pricktestlösung Շվեյցարիա - ֆրանսերեն - Swissmedic (Swiss Agency for Therapeutic Products)

prick-test aspergillus fumigatus pricktestlösung

allergopharma ag - fungi allergeni extractum (aspergillus fumigatus) - pricktestlösung - fungi allergeni extractum (aspergillus fumigatus) 10000 u., natrii chloridum, glycerolum, phenolum, aqua ad iniectabile ad solutionem pro 1 ml. - diagnostic de l'allergie - allergène: diagnostic

Ruberkehl D5 Buvable en gouttes et Frotter Շվեյցարիա - ֆրանսերեն - Swissmedic (Swiss Agency for Therapeutic Products)

ruberkehl d5 buvable en gouttes et frotter

ebi-pharm ag - aspergillus ruber aquos d5 - buvable en gouttes et frotter - aspergillus ruber aquos d5 dilutio. - gemäss homöopathischem arzneimittelbild bei allergischen erkrankungen der oberen und unteren atemwege wie fließschnupfen, sinusitis und bronchitis - les médicaments homéopathiques

Cancidas (previously Caspofungin MSD) Եվրոպական Միություն - ֆրանսերեն - EMA (European Medicines Agency)

cancidas (previously caspofungin msd)

merck sharp & dohme b.v. - caspofungin (as acetate) - candidiasis; aspergillosis - antimycotiques pour une utilisation systémique - treatment of invasive candidiasis in adult or paediatric patients;treatment of invasive aspergillosis in adult or paediatric patients who are refractory to or intolerant of amphotericin b, lipid formulations of amphotericin b and / or itraconazole. refractoriness is defined as progression of infection or failure to improve after a minimum of seven days of prior therapeutic doses of effective antifungal therapy;empirical therapy for presumed fungal infections (such as candida or aspergillus) in febrile, neutropaenic adult or paediatric patients.

Lacdigest Comprimés à croquer Շվեյցարիա - ֆրանսերեն - Swissmedic (Swiss Agency for Therapeutic Products)

lacdigest comprimés à croquer

recordati ag - tilactasum, aspergillus oryzae - comprimés à croquer - tilactasum 60 mg ex aspergillus oryzae corresp. 2250 u., glucosum monohydricum 40 mg, amylum pregelificatum, cellulosum microcristallinum, magnesii stearas, glucosum 20 mg, natrii citras dihydricus corresp. natrium 0.53 mg, carmellosum calcicum, pro compresso. - supplémentation enzymatique cas d'intolérance au lactose de renoncer - synthetika

Mucor racemosus compositum Շվեյցարիա - ֆրանսերեն - Swissmedic (Swiss Agency for Therapeutic Products)

mucor racemosus compositum

ebi-pharm ag - aspergillus niger d12, 0,5 ml / 1ml; mucor racemosus, d12, 0.5 ml / 1ml - tropfen / spray - d - aspergillus niger, d12, 0,5 ml / 1 ml; mucor racemosus, d12, 0,5 ml / 1 ml - homöopathisch

Caspofungin Accord Եվրոպական Միություն - ֆրանսերեն - EMA (European Medicines Agency)

caspofungin accord

accord healthcare s.l.u. - acétate de caspofungine - candidiasis; aspergillosis - antimycotiques pour une utilisation systémique - traitement de la candidose invasive chez les adultes ou pour les patients pédiatriques. le traitement de l'aspergillose invasive chez les adultes ou les enfants, les patients qui sont réfractaires ou intolérants à l'amphotéricine b, les formulations lipidiques de l'amphotéricine b et/ou à l'itraconazole. la période réfractaire est définie comme la progression de l'infection ou de l'absence d'amélioration après un minimum de 7 jours avant l'administration de doses thérapeutiques efficaces de traitement antifongique. le traitement empirique des présumée infections fongiques (comme le candida ou aspergillus) dans fébrile, neutropaenic adultes ou pédiatrie.